Research

Life Sciences & Biotechnology

Title :

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis

Area of research :

Life Sciences & Biotechnology, Medical Sciences

Focus area :

Chronic Diseases

Principal Investigator :

Dr Shalimar, Associate Professor, All India Institute of Medical Sciences (AIIMS), New Delhi

Timeline Start Year :

2017

Timeline End Year :

2022

Contact info :

Details

Total Budget (INR):

10,00,000

Organizations involved